Johns Hopkins
Brain Cancer Study Reveals Immune Cell Populations Linked to Aggressive Subtype
Researchers used single-cell RNA sequencing and spatial transcriptomics to find two myeloid-derived suppressor cell subsets supporting the growth of an aggressive glioblastoma.
At the AMP annual meeting last week, a Johns Hopkins researcher detailed an Oxford Nanopore flu sequencing workflow optimized with novel New England Biolabs reagents.
The research team looked at cell-free DNA fragmentation profiles across the genome combined with measurements of two key biomarkers to detect ovarian cancer.
Previse Awarded $1.8M NIH Grant to Develop Esophageal Cancer Test
The Maryland-based firm said that the money will support the development and commercialization of a screening test for esophageal squamous cell carcinoma.
Alveo Tech, Global Virus Network, Johns Hopkins Partner on POC MDx Assay Development Program
The partners intend to equip labs in their networks with Alveo test systems for assay development.